Sickle cell gene therapies offer new hope, but access remains a major challenge
Ringkasan AI belum tersedia — yang ditampilkan adalah cuplikan dari sumber asli.
FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.
Sumber (1)
- CNBC: Sickle cell gene therapies offer new hope, but access remains a major challengeTerbit 16 Okt 2026, 23.50 · pertama terlihat 17 Okt 2026, 02.17